Clinical Trials Logo

Filter by:
NCT ID: NCT01090791 Terminated - Critically Ill Clinical Trials

FLOTRAC/VIGILEO in Acute Circulatory Failure

FLOVAC
Start date: May 2011
Phase: N/A
Study type: Observational

Acute circulatory failure may be related to hypovolemia. Fluid loading increases stroke volume in approximatively half of challenges. Determining fluid responsiveness prevents unnecessary fluid loading. Passive leg raising (PLR) provides a transient increase of 300 ml in venous return for a short time. The measurement of stroke volume (SV) before and after a PLR test allows physician to detect fluid responsiveness, when stroke volume increases is higher than 15 %. Beside thermodilution, the use of non invasive device to measure stroke volume becomes largely employed. Arterial Pressure based Cardiac Output (APCO), provided by the Flotrac/Vigileo system, does not required specific materials nor repeated calibration. The third generation software is believed to be more accurate and more precise for SV measurement. The aim of this study is to test the performance of the Flotrac/Vigileo device in a situation of rapid venous return changes induced by PLR and then by fluid loading. Patients will be classify posteriorly in responders and non responders, according to the magnitude of the fluid loading-induced SV changes measured by transthoracic echocardiography.

NCT ID: NCT01089257 Terminated - Clinical trials for Obstructive Sleep Apnea Syndrome

Cardiovascular Impairments and Obstructive Sleep Apnea Syndrome

INFRASAS
Start date: November 2007
Phase:
Study type: Observational

Which are the anthropometric parameters and/or of severity of the syndrome of apnea of sleep (SAS) which make it possible to anticipate occurred of vascular anomalies, anatomical and/or functional precociously found among patients SAS? Secondary objectives: 1. Which are the anthropometric parameters and/or of severity of SAS allowing to anticipate occurred of early of the cardiac function and/or rhythmic anomalies found among patients SAS? 2. Do there exist biological markers who allow to anticipate the early vascular lesions or the anomalies beginners of the cardiac function? 3. Which are the cardiovascular effects of a treatment of SAS by Continuous Positive Pressure (PC) after 3 to 6 months of treatment? 4. Do the identified early cardiovascular attacks and/or the biological anomalies make it possible to predict occurred of cardiovascular events in this population of patients carrying SAS (followed longitudinal at 5 years)?

NCT ID: NCT01086761 Terminated - Clinical trials for Wet Age-Related Macular Degeneration

Study of MP0112 Intravitreal Injection in Patients With Wet Age Related Macular Degeneration

Start date: March 2010
Phase: Phase 1
Study type: Interventional

The purpose of this study is to assess the safety and tolerability of MP0112 (a novel, potentially long acting VEGF inhibitor) in patients with wet Age Related Macular Degeneration.

NCT ID: NCT01083615 Terminated - Clinical trials for Hormone Refractory Prostate Cancer

A Study Evaluating the Pain Palliation Benefit of Adding Custirsen to Docetaxel Retreatment or Cabazitaxel as Second Line Therapy in Men With Metastatic Castrate Resistant Prostate Cancer (mCRPC)

Start date: March 2010
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine if the addition of study drug (custirsen) can provide durable pain palliation for castrate resistant prostate cancer patients receiving docetaxel retreatment or cabazitaxel as a second line therapy.

NCT ID: NCT01083472 Terminated - Hernia Clinical Trials

Repair of Challenging Abdominal Wall Defects: Strattice(TM) TM in Abdominal Wall Repair (StAR)

StAR
Start date: March 2010
Phase: Phase 4
Study type: Interventional

The objective of this study is to compare the incidence of post-repair wound related complications, including hernia occurrence/recurrence, between challenging abdominal wall defects repaired with Strattice(TM) Reconstructive Tissue Matrix (TM) and those managed by standard repair. It is hypothesized that the use of Strattice(TM) TM to reinforce the repair will reduce the incidence of these post-repair complications.

NCT ID: NCT01082887 Terminated - Metastatic Melanoma Clinical Trials

A Study of Immunotherapy With TIL (Tumor Infiltrating Lymphocytes) in Combination With Intra-tumoral Injections of Interferon Gamma-adenovirus (Ad-IFNg) in Patients With Stage IIIc or Stage IV Metastatic Melanoma (AJCC)(Protocol TIL-Ad-INFg)

Start date: January 2010
Phase: Phase 1/Phase 2
Study type: Interventional

The main objective of this study is to evaluate the clinical and biologic toxicity of cell therapy by adoptive transfer of TIL in combination with intra-tumoral injections of Ad-INFg.

NCT ID: NCT01079767 Terminated - Liver Cancer Clinical Trials

Temsirolimus in Treating Patients With Advanced Liver Cancer and Cirrhosis

Start date: January 2010
Phase: Phase 2
Study type: Interventional

RATIONALE: Temsirolimus may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. PURPOSE: This phase II trial is studying how well temsirolimus works in treating patients with advanced liver cancer and cirrhosis.

NCT ID: NCT01079429 Terminated - Clinical trials for Monoclonal Gammopathy of Undetermined Significance

Study of DNA Copy Numbers Variations and Gene Expression Profile of Bone Marrow Plasma Cells From MGUS and SMM.

GENOMGUS
Start date: January 12, 2009
Phase:
Study type: Observational

The purpose of this study is to describe DNA copy number variations and gene expression profiles of bone marrow plasma cells of monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM). The final objective is to search for correlations with the risk of progression in order to establish a predictive model of early malignant transformation.

NCT ID: NCT01077791 Terminated - Schizophrenia Clinical Trials

A Study of a Remediation Program of Social Cognition in Schizophrenia

REMEDCOG
Start date: July 2008
Phase: Phase 2
Study type: Interventional

Theory of mind (ability to infer others' intention, emotion, etc) is known to be altered in patients with schizophrenia and its deficit to be correlated with their decreased social proficiency. We designed a novel cognitive therapy, that makes use of videos, aimed at learning a better use of contextual information to infer others' intentions. The aim of this study is to demonstrate, in schizophrenic patients, a quantitative improvement of their ability to infer intention of others induced by this novel training program. A secondary aim is to measure the cerebral correlates (MEG, PeV) of this social cognitive function and of its anticipated improvement.

NCT ID: NCT01077778 Terminated - Pulmonary Embolism Clinical Trials

Magnetic Resonance Diagnosis of Pulmonary Embolism

IRM-EP
Start date: March 2007
Phase: N/A
Study type: Observational

- The purpose of this study is to evaluate the diagnostic accuracy of thoracic magnetic resonance imaging with gadolinium-enhanced, unenhanced and perfusion sequences in patients with clinically suspected acute pulmonary embolism - Thoracic CT angiography (CTA) will serve as reference standard - Result of MRI will not interfere with patients' management - Untreated patients with negative CTA will have 3-month follow-up to verify they were free of thrombose-embolic disease